Metabolic Cancer Support Program | FMD & HBOT Algarve

METABOLIC ONCOLOGY SUPPORT – 3-MONTH PROGRAM

A STRUCTURED METABOLIC APPROACH

3-MONTH PROGRAM | 5 DAYS PER MONTH
COMBINING FMD | HBOT | ADVANCED THERAPIES


Looking for a structured, integrative approach to support your health over time?

This program is designed to support the body at a cellular and metabolic level, using repeated cycles of targeted intervention and recovery.


Understanding Tumor Metabolism

Many tumor cells rely on specific “feeding pathways” to grow and survive.

The two main ones are:

  • Glucose → used for rapid energy production

  • Glutamine → used for cell growth, repair and survival

Unlike healthy cells, tumor cells often depend heavily on these pathways and are less flexible when they are disrupted.


How the Program Impacts These Pathways

This protocol is designed to reduce access to these fuels while increasing cellular stress, creating a less favorable environment for dysfunctional cells.

Fasting Mimicking Diet (FMD)

  • Reduces glucose availability

  • Lowers growth signals (IGF-1, mTOR)

  • Decreases reliance on glutamine pathways

👉 Result: less fuel + reduced growth signaling


Hyperbaric Oxygen Therapy (HBOT)

  • Increases oxygen delivery

  • Promotes oxidative stress (ROS)

  • Challenges cells with impaired metabolism

👉 Result: increased pressure on vulnerable cells


Combined Effect

  • Less fuel (glucose & glutamine signaling)

  • More stress (oxygen & ROS)

👉 This reduces the ability of certain cells to adapt and thrive


Program Structure

Each month includes a 5-day on-site cycle, repeated over 3 months:


Days 1–5: Metabolic Phase (Core Protocol)

Goal: Reset metabolism and stimulate cellular adaptation

  • Fasting Mimicking Diet (FMD)

  • Daily Hyperbaric Oxygen Therapy (HBOT) (90–120 min)

  • PEMF (daily, 20–30 min)

  • Infrared Sauna (3 sessions)


Between Cycles (At Home)

Between each monthly cycle, the focus is on stabilization and recovery:

  • Balanced nutrition

  • Light physical activity

  • Ongoing support via the Hippocrates App

👉 This phase allows the body to:

  • Adapt

  • Recover

  • Maintain metabolic improvements


What’s included (per month):

5-day Protocol including: 

  • 5-Day Fasting Mimicking Diet (FMD)

  • Intense Hyperbaric Oxygen Therapy (HBOT) during FMD

  • PEMF sessions

  • Infrared Sauna sessions

  • Personalized guidance

  • Access to the Hippocrates App


Important:

  • This program is a supportive, integrative approach

  • It does not replace medical treatment

  • Medical screening may be required


Why choose this program:

  • Targets key metabolic pathways (glucose & glutamine)

  • Enhances oxygenation and cellular efficiency

  • Promotes metabolic balance and resilience

  • Structured over 3 months for progressive results


Scientific References

Longo VD & Mattson MP (2014). Fasting: Molecular mechanisms and clinical applications. Cell Metabolism.

Brandhorst S et al. (2015). A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration. Cell Metabolism.

Blaževitš O et al. (2023). Fasting mimicking diets in cancer prevention and therapy.

Pastora-Sesín C et al. (2024). Fasting Mimicking Diet and cancer therapy: metabolic and molecular mechanisms.

Warburg O (1956). On the origin of cancer cells. Science.

Halma MTJ et al. (2023). Cancer metabolism as a therapeutic target.

Poff AM, Ari C, D’Agostino DP, Seyfried TN (2013). The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One.

Poff AM et al. (2013). Targeting the Warburg effect with metabolic therapy: ketogenic diet and hyperbaric oxygen therapy. FASEB Journal.

Seyfried TN (2012). Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. Wiley.

Seyfried TN et al. (2017). Press-Pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutrition & Metabolism.

Colombo E et al. (2025). Fasting mimicking diet and ketogenic diet in cancer: metabolic and microbiome perspectives. Frontiers in Oncology.


👉 These approaches are:

Supported by preclinical and emerging clinical research

Used as adjunct strategies

Not replacements for standard oncology care